Literature DB >> 7259196

Identity of the active site flavin-peptide fragments from the human "A"-form and the bovine "B"-form of monoamine oxidase.

J Nagy, J I Salach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259196     DOI: 10.1016/0003-9861(81)90523-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  6 in total

1.  The primary structure of bovine monoamine oxidase type A. Comparison with peptide sequences of bovine monoamine oxidase type B and other flavoenzymes.

Authors:  J F Powell; Y P Hsu; W Weyler; S A Chen; J Salach; K Andrikopoulos; J Mallet; X O Breakefield
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2.

Authors:  H Yi; W Maruyama; Y Akao; T Takahashi; K Iwasa; M B H Youdim; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  2005-04-22       Impact factor: 3.575

Review 3.  Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs.

Authors:  M Mewies; W S McIntire; N S Scrutton
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

4.  Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.

Authors:  J E Pintar; X O Breakefield
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

5.  Cloning, sequencing and heterologous expression of the monoamine oxidase gene from Aspergillus niger.

Authors:  B Schilling; K Lerch
Journal:  Mol Gen Genet       Date:  1995-05-20

6.  Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism.

Authors:  Alen Albreht; Irena Vovk; Janez Mavri; Jose Marco-Contelles; Rona R Ramsay
Journal:  Front Chem       Date:  2018-05-28       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.